172 results on '"van der Stelt, Mario"'
Search Results
2. A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
3. Structural basis of selective cannabinoid CB2 receptor activation
4. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor
5. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
6. Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity.
7. P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism.
8. Structure–Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors.
9. Discovery of a Cannabinoid CB2 Receptor Fluorescent Probe Based on a Pyridin-2-yl-benzyl-imidazolidine-2,4-dione Scaffold.
10. Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala
11. Discovery of a Photoaffinity Probe that Captures the Active Conformation of the Cannabinoid CB2 Receptor.
12. PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells
13. Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice
14. Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib
15. Regulation of Adipose Tissue Metabolism by the Endocannabinoid System
16. Piperidine and octahydropyrano[3,4-c] pyridine scaffolds for drug-like molecular libraries of the European Lead Factory
17. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
18. CB1 Cannabinoid Receptors and On-Demand Defense against Excitotoxicity
19. Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis
20. Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.
21. A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance.
22. Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
23. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition
24. Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
25. Cyclopentitol as a scaffold for a natural product-like compound library for drug discovery
26. Chemical tools to modulate 2‐arachidonoylglycerol biosynthesis
27. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
28. EFMC: Trends in Medicinal Chemistry and Chemical Biology.
29. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes
30. Understanding and Targeting the Endocannabinoid System with Activity‐Based Protein Profiling.
31. Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the ex vivo human placenta.
32. 2-AG-Mediated Control of GABAergic Signaling Is Impaired in a Model of Epilepsy.
33. Chemical Proteomics Reveals Antibiotic Targets of Oxadiazolones in MRSA.
34. Chemical Probes to Control and Visualize Lipid Metabolism in the Brain.
35. Comparative Photoaffinity Profiling of Omega‑3 Signaling Lipid Probes Reveals Prostaglandin Reductase 1 as a Metabolic Hub in Human Macrophages.
36. Live‐Cell Imaging of Sterculic Acid—a Naturally Occurring 1,2‐Cyclopropene Fatty Acid—by Bioorthogonal Reaction with Turn‐On Tetrazine‐Fluorophore Conjugates.
37. Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.
38. Plasma Levels of Endocannabinoids and Their Analogues Are Related to Specific Fecal Bacterial Genera in Young Adults: Role in Gut Barrier Integrity.
39. Cannabinoid receptors and their role in neuroprotection
40. Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases
41. Acute neuronal injury, excitotoxicity, and the endocannabinoid system
42. Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy.
43. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization
44. Clickable Vitamins as a New Tool to Track Vitamin A and Retinoic Acid in Immune Cells.
45. Endovanilloids: Putative endogenous ligands of transient receptor potential vanilloid 1 channels
46. Metabolic Fate of Endocannabinoids
47. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
48. In Vivo Excitotoxicity Induced by Ouabain, a Na+/K+-ATPase Inhibitor
49. Protein Dynamics Influence the Enzymatic Activity of Phospholipase A/Acyltransferases 3 and 4.
50. Structure–Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N‑Acylphosphatidylethanolamine Phospholipase D.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.